Ketanserin

This classification denotes a serotonin antagonist with the molecular formula C22H22FN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 97F9DE4CT4, chemically known as 2,4(1h,3h)-quinazolinedione, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)- but generally known as ketanserin, which bears US NIH Compound Identifier 3822. European Medicines Agency schedules Ketanserin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08366MIG. The term KETANSERIN is an International Non-Proprietary Name. World Health Organization schedules ketanserin in its Anatomical Therapeutic Chemical (ATC) Classification. KETANSERIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ketanserin under HS 29335995 and SITC 51576. As of Q4 2014, KETANSERIN remains the US FDA Preferred Term for this commodity. Ketanserin bears US NLM identifiers UMLS ID C0022616 and NCI Concept Code C604. SMILES: Fc1ccc(C(=O)C2CCN(CC2)CCn2c(=O)c3c([nH]c2=O)cccc3)cc1.